212 related articles for article (PubMed ID: 31402980)
1. Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer.
Mei J; Hao L; Liu X; Sun G; Xu R; Wang H; Liu C
Biomark Res; 2019; 7():16. PubMed ID: 31402980
[TBL] [Abstract][Full Text] [Related]
2. The prognostic values of the peroxiredoxins family in ovarian cancer.
Li S; Hu X; Ye M; Zhu X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104402
[No Abstract] [Full Text] [Related]
3. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
4. Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer.
Xu R; Pan J; Mei J; Zhang Q
Biomed Res Int; 2020; 2020():3948183. PubMed ID: 32382548
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis the characterization of peroxiredoxins in pan-cancer.
Gao L; Meng J; Yue C; Wu X; Su Q; Wu H; Zhang Z; Yu Q; Gao S; Fan S; Zuo L
Cancer Cell Int; 2021 Jul; 21(1):366. PubMed ID: 34246267
[TBL] [Abstract][Full Text] [Related]
6. Prognostic roles of mRNA expression of peroxiredoxins in lung cancer.
Chen L; Huang C; Yang X; Zhang Q; Chen F
Onco Targets Ther; 2018; 11():8381-8388. PubMed ID: 30568461
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma.
Xu M; Xu J; Zhu D; Su R; Zhuang B; Xu R; Li L; Chen S; Ling Y
J Transl Med; 2021 Mar; 19(1):126. PubMed ID: 33771165
[TBL] [Abstract][Full Text] [Related]
8. The Prognosis Of Peroxiredoxin Family In Breast Cancer.
Wang G; Zhong WC; Bi YH; Tao SY; Zhu H; Zhu HX; Xu AM
Cancer Manag Res; 2019; 11():9685-9699. PubMed ID: 31814764
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Zhang X; Gao F; Li N; Zhang J; Dai L; Yang H
J Cancer; 2020; 11(11):3124-3143. PubMed ID: 32231717
[No Abstract] [Full Text] [Related]
10. Characterization of the expression and prognostic value of 14-3-3 isoforms in breast cancer.
Mei J; Liu Y; Xu R; Hao L; Qin A; Chu C; Zhu Y; Liu X
Aging (Albany NY); 2020 Oct; 12(19):19597-19617. PubMed ID: 33052135
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.
Szeliga M
Neurochem Int; 2022 Feb; 153():105256. PubMed ID: 34968631
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
Basu A; Banerjee H; Rojas H; Martinez SR; Roy S; Jia Z; Lilly MB; De León M; Casiano CA
Prostate; 2011 May; 71(7):755-65. PubMed ID: 21031435
[TBL] [Abstract][Full Text] [Related]
14. Systematic Characterization of Expression Patterns and Immunocorrelations of Formin-Like Genes in Breast Cancer.
Gao E; Wang X; Wang F; Deng S; Xia W; Wang R; Wang X; Zhao X; Qian H
Biomed Res Int; 2022; 2022():8577821. PubMed ID: 36124068
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
He L; Lin Y; Huang P; Pan H
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
[TBL] [Abstract][Full Text] [Related]
17. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
[TBL] [Abstract][Full Text] [Related]
18. Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer.
Xu WX; Song W; Jiang MP; Yang SJ; Zhang J; Wang DD; Tang JH
Front Genet; 2021; 12():637887. PubMed ID: 33815471
[TBL] [Abstract][Full Text] [Related]
19. Mining the prognostic significance and immune infiltration of
Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed DAAM1 correlates with metastasis and predicts poor prognosis in breast cancer.
Mei J; Xu B; Hao L; Xiao Z; Liu Y; Yan T; Zhu Y
Pathol Res Pract; 2020 Mar; 216(3):152736. PubMed ID: 31757662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
